What is the role of prophylactic antiemetics in high-emetogenic chemotherapy?

• A. To prevent acute and delayed nausea and vomiting and improve nutrition and quality of life
• B. To treat established nausea after it occurs
• C. To replace hydration
• D. To prevent mucositis

Answer: (A)

Preventing both acute and delayed chemotherapy-induced nausea and vomiting with a preemptive antiemetic plan is essential when using high-emetogenic regimens. The body's emetic response occurs in two phases: an immediate phase within the first 24 hours driven largely by serotonin release in the gut, and a delayed phase that can follow for several days. Administering a combination antiemetic regimen before chemotherapy and continuing it afterward targets multiple pathways, substantially reducing the risk and severity of emesis. This proactive approach helps patients maintain oral intake, stay hydrated, preserve nutrition, and enjoy a better quality of life during treatment. It’s about prevention rather than treatment after symptoms start. Hydration is important but separate from the antiemetic strategy, and antiemetics do not prevent mucositis, which is governed by a different toxicity and management plan.